As of 12:30 PM on the 5th, Celltrion is trading at 351,000 KRW, up 2.78% from the previous day. This represents a 13.23% increase compared to January 22. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Today, foreigners have a tentative net sell of 6,621 shares of Celltrion, and institutions have a net sell of 2,000 shares. Over the past five days, individual investors have net sold 871,446 shares, while foreigners and institutions have net bought 930,705 shares and 7,959 shares, respectively.
On February 4, Celltrion became an issue in the market with the headline 'Eun Seong-su says Korean individual clusters are difficult, decline.'
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
